Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The International Center for Personalized Medicine (ICPM) is a specialized healthcare and research institution focused on advanced molecular imaging and precision oncology. Based in Germany, the center specializes in theranostics, a field that combines targeted diagnostic imaging with personalized radionuclide therapy. ICPM provides cutting-edge services including PET/CT imaging and targeted therapies for various cancers, most notably prostate cancer and neuroendocrine tumors. The center operates as a hub for international patients seeking advanced nuclear medicine treatments that are often unavailable in standard clinical settings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Center for Personalized Medicine.